The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 13×
“In most cases, the dose required to suppress NF-kB-dependent reporter activity was similar to that needed for inhibition of NF-kB DNA-binding activity.”
BackgroundInfluentialSignalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · cited 3×
“That both TNF and NF-kB play a major role in inflammation is well established (Bharti and Aggarwal, 2002; Aggarwal, 2003).”
BackgroundMethodSelf-citationInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Self-citationNF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6509 · Cited by 879
Self-citationAnti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31315 · Cited by 647 · cited 1×
“NSAIDs inhibit TNF-induced and NF-kB-regulated protein expression Through activation of NF-kB, TNF induces cyclin D1 and COX-2, both of which have NF-kB-binding sites in their promoters (Yamamoto et al., 1995; Guttridge et al., 1999; Hinz et al., 1999).”
BackgroundNuclear factor-kappa B and cancer: its role in prevention and therapy
Bharti, A. C., & Aggarwal, B. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01154-1 · Cited by 510
Self-citationTakada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S., & Aggarwal, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212389200 · Cited by 495
Self-citationSulindac Inhibits Activation of the NF-κB Pathway
Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 494
Inoue, H., Yokoyama, C., Hara, S., Tone, Y., & Tanabe, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24965 · Cited by 479 · cited 1×
“These results also point to a more complex regulation of COX-2 expression besides NF-kB (Inoue et al., 1995; Miller et al., 1998).”
BackgroundJack, D. B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07087-6 · Cited by 256
Ashikawa, K., Majumdar, S., Banerjee, S., Bharti, A. C., Shishodia, S., & Aggarwal, B. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6490 · Cited by 238
Self-citationAspirin, platelets, and thrombosis: theory and practice
Roth, G., & Calverley, D. (1994) · Blood · doi:10.1182/blood.v83.4.885.885 · Cited by 232
Takada, Y., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3278 · Cited by 212
Self-citationStark, L. A., Din, F. V. N., Zwacka, R. M., & Dunlop, M. G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0529fje · Cited by 191
Nasuhara, Y., Adcock, I. M., Catley, M., Barnes, P. J., & Newton, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19965 · Cited by 162
Chuang, S.-E., Yeh, P.-Y., Lu, Y.-S., Lai, G.-M., Liao, C.-M., Gao, M., & Cheng, A.-L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00931-0 · Cited by 159
Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB
Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., Bräutigam, L., Grösch, S., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0716fje · Cited by 153
Ferlini, C., Scambia, G., Marone, M., Distefano, M., Gaggini, C., Ferrandina, G., Fattorossi, A., Isola, G., Panici, P. B., & Mancuso, S. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690042 · Cited by 136
Takada, Y., Khuri, F. R., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400963200 · Cited by 113
Self-citationBharti, A. C., Takada, Y., Shishodia, S., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308062200 · Cited by 104
Self-citationMiller, C. J., Zhang, M., He, Y., Zhao, J., Pelletier, J., Martel‐Pelletier, J., & Battista, J. A. D. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980615)69:4<392::aid-jcb2>3.0.co;2-i · Cited by 87
NF-κB signaling pathway as a target for human tumor radiosensitization
Jung, M., & Dritschilo, A. (2001) · Seminars in Radiation Oncology · doi:10.1053/srao.2001.26034 · Cited by 86
Modulation of transcription factor NF‐κB by enantiomers of the nonsteroidal drug ibuprofen
Scheuren, N., Bang, H., Münster, T., et al. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701652 · Cited by 84
Kazmi, S. M. I., Plante, R. K., Visconti, V., Taylor, G. R., Zhou, L., & Lau, C. Y. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570214 · Cited by 76
Bryant, C. E., Farnfield, B. A., & Janicke, H. J. (2003) · American Journal of Veterinary Research · doi:10.2460/ajvr.2003.64.211 · Cited by 56
COX-2 inhibition and prevention of cancer
Giercksky, K.-E. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0237 · Cited by 42
Takada, Y., & Aggarwal, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213237200 · Cited by 36
Self-citationAbsence of nuclear factor κB inhibition by NSAIDs in hepatocytes
Callejas, N. A., Casado, M., Boscá, L., & Martín‐Sanz, P. (2002) · Hepatology · doi:10.1053/jhep.2002.31163 · Cited by 25
Hass, R., Brach, M. A., Gunji, H., Kharbanda, S. M., & Kufe, D. W. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90474-w · Cited by 22
Cited by
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Self-citationInhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
Self-citationNuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Park, M., & Hong, J. (2016) · Cells · doi:10.3390/cells5020015 · Cited by 627
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596
Metadata
- Authors
- Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B.
- Venue
- Oncogene
- Published
- 2004-10-18
- Volume
- 23
- Issue
- 57
- Pages
- 9247-9258
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2111074132
- Cited by
- 310
- References
- 40
- FWCI
- 14.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.